Skip to main content

Precision Power Boosts Case for Genomics ETF

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is already at the center of a variety of disruptive, innovative healthcare ideas. One of the emerging concepts ARKG is levered to is precision medicine. The intersection of precision medicine and genomics could be the next growth frontier...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.